Evidence map›Paper›PMID 10938117›Full record

ArticleMolecular and cellular biology2000

Sgs1 helicase activity is required for mitotic but apparently not for meiotic functions.

A Miyajima, M Seki, F Onoda, M Shiratori, N Odagiri, K Ohta, Y Kikuchi, Y Ohno, T Enomoto

Open access · greenAbstract read
In one paragraph

Article in Molecular and cellular biology, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 48 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. The RecQ DNA helicases in DNA repair.Annual review of genetics · 2010
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. A yeast gene, MGS1, encoding a DNA-dependent AAA(+) ATPase is required to maintain genome stability.Proceedings of the National Academy of Sciences of the United States of America · 2001
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

A MiyajimaDivision of Pharmacology, Biological Safety Research Center, National Institute of Health Sciences, Setagaya-ku, Tokyo 158-8501, Japan.
M Seki
F Onoda
M Shiratori
N Odagiri
K Ohta
Y Kikuchi
Y Ohno
T Enomoto
Tohoku University · JPNational Institute of Health Sciences · JPBunkyo University · JPRIKEN · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The SGS1 gene of Saccharomyces cerevisiae is a homologue for the Bloom's syndrome and Werner's syndrome genes. The disruption of the SGS1 gene resulted in very poor sporulation, and the majority of the cells were arrested at the mononucleated stage. The recombination frequency measured by a return-to-growth assay was reduced considerably in sgs1 disruptants. However, double-strand break formation, which is a key event in the initiation of meiotic DNA recombination, occurred; crossover and noncrossover products were observed in the disruptants, although the amounts of these products were slightly decreased compared with those in wild-type cells. The spores produced by sgs1 disruptants showed relatively high viability. The sgs1 spo13 double disruptants sporulated poorly, like the sgs1 disruptants, but spore viability was reduced much more than with either sgs1 or spo13 single disruptants. Disruption of the RED1 or RAD17 gene partially alleviated the poor-sporulation phenotype of sgs1 disruptants, indicating that portions of the population of sgs1 disruptants are blocked by the meiotic checkpoint. The poor sporulation of sgs1 disruptants was complemented with a mutated SGS1 gene encoding a protein lacking DNA helicase activity; however, the mutated gene could suppress neither the sensitivity of sgs1 disruptants to methyl methanesulfonate and hydroxyurea nor the mitotic hyperrecombination phenotype of sgs1 disruptants.

Indexed as

EndodeoxyribonucleasesExodeoxyribonucleasesMeiosisMitosisSaccharomyces cerevisiae ProteinsAdenosine TriphosphatasesCell Cycle ProteinsDNA-Binding ProteinsDNA HelicasesDNA RepairDNA Topoisomerases, Type IEnzyme InhibitorsFlow CytometryFungal ProteinsGenotypeHydroxyureaAdenosine TriphosphatasesBloom syndrome proteinCell Cycle ProteinsDNA-Binding ProteinsDNA HelicasesDNA Topoisomerases, Type IEndodeoxyribonucleasesEnzyme InhibitorsExodeoxyribonucleasesFungal ProteinsHydroxyureaMethyl MethanesulfonateMRE11 protein, S cerevisiaeMutagensNuclear ProteinsRAD17 protein, S cerevisiaeRecQ HelicasesRED1 protein, S cerevisiaeSaccharomyces cerevisiae ProteinsSGS1 protein, S cerevisiaeSPO13 protein, S cerevisiaeWerner Syndrome HelicaseWRN protein, human

Identifiers

PMID10938117
PMCPMC86115
OpenAlexW2134312430

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.